I

Immunic Therapeutics

Clinical-stage biopharma developing oral autoimmune therapies

Vice President, Market Access

Account ManagementConfirmed live in the last 24 hours
Full-timeRemote in USA$285k - $340k /yrRemote

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 15 years of progressive leadership experience within the pharmaceutical or biotechnology industry.
  • Demonstrated success leading U.S. Market Access organizations for specialty pharmaceutical products.
  • Deep understanding of multiple sclerosis competitive dynamics, payer landscape, specialty pharmacy networks, treatment centers, reimbursement environment, and negotiations with commercial payers, PBMs, Medicare Part D plans, federal healthcare systems, specialty pharmacies, and integrated health systems.

Responsibilities

  • Lead U.S. Market Access strategy and organization build for the vidofludimus calcium launch, covering pricing, contracting, reimbursement, and distribution.
  • Develop integrated access strategies spanning Commercial, Medicare, Medicaid, VA, DoD, and other government channels.
  • Own national payer strategy and negotiate with health plans, PBMs, IDNs, health systems, and specialty pharmacies.
  • Build payer value propositions using clinical, economic, and real-world evidence to drive favorable formulary coverage.
  • Set pricing strategy, gross-to-net assumptions, and specialty pharmacy, trade, and distribution frameworks, ensuring launch-ready operations.
  • Partner with Medical Affairs and HEOR on payer evidence strategy, AMCP dossiers, and value communication, and support post-launch evidence generation.
  • Serve on the Commercial Leadership Team, coordinating with Marketing, Sales, Medical, Regulatory, Finance, Legal, and Supply Chain on launch readiness.
  • Design and build the Market Access organizational structure, capabilities, and metrics across Payer Strategy, Marketing, Pricing and Contracting, Trade, Analytics, and Excellence functions.
  • Recruit and lead a field Market Access team of National, Federal, and Regional Account Managers and Field Reimbursement Managers.
  • Set field deployment strategy, including territories, hiring, training, and incentives, and ensure close collaboration with Sales and Medical Affairs to maximize adoption.

Desired Qualifications

  • An MBA, PharmD, MPH, or other advanced degree is preferred.
  • Direct experience leading U.S. Market Access strategy for one or more multiple sclerosis product launches is strongly preferred.
  • Experience building commercial infrastructure within an emerging biotechnology company or first-launch organization is strongly preferred.
  • Candidates who have played a significant leadership role in commercializing successful multiple sclerosis therapies will be strongly favored.

About the Company

Immunic Therapeutics

Clinical-stage biopharma developing oral autoimmune therapies

Immunic Therapeutics develops oral therapies for chronic inflammatory and autoimmune diseases and is in clinical-stage development. Its lead candidate, vidofludimus calcium (IMU-838), is an oral small molecule that activates the Nurr1 receptor to protect nerve cells and inhibits DHODH to calm overactive immune responses; its pipeline also includes IMU-856, a SIRT6 modulator aimed at restoring intestinal barrier function, with IMU-381 in preclinical GI programs. The company emphasizes oral, small-molecule drugs with dual actions and pursues partnerships or licensing for commercialization rather than relying on near-term product revenue. Its goal is to advance its drug candidates through clinical trials toward commercialization, potentially via collaborations with larger pharma companies.

Company size
51-200
Company stage
IPO
Headquarters
New York City, New York
Founded
2016

Recently Posted Jobs

Explore more opportunities at Immunic Therapeutics

See more jobs